| Titre : | Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working? (2001) |
| Auteurs : | V. D. HOPE ; A. JUDD ; M. HICKMAN |
| Type de document : | Article : Périodique |
| Dans : | American Journal of Public Health (Vol.91, n°1, January 2001) |
| Article en page(s) : | 38-42 |
| Langues: | Anglais |
| Discipline : | MAL (Maladies infectieuses / Infectious diseases) |
| Mots-clés : |
Thésaurus mots-clés HEPATITE ; PREVALENCE ; ENQUETE ; VOIE INTRAVEINEUSE ; REDUCTION DES RISQUES ET DES DOMMAGESThésaurus géographique ROYAUME-UNI |
| Résumé : |
OBJECTIVES: This study sought to establish the prevalence of hepatitis C antibodies (anti-HCV) and hepatitis B antibodies (anti-HBc) among injection drug users in England and Wales.
METHODS: A voluntary cross-sectional survey collected oral fluid samples and behavioral information; 2203 injectors were recruited through drug agencies, and 758 were recruited in the community. RESULTS: Prevalence was 30% for anti-HCV, 21% for anti-HBc, and 0.9% for HIV antibodies. Anti-HCV prevalence rates were significantly greater among those with longer injecting careers, those in older age groups, those residing in London, those recruited in drug agencies, those positive for anti-HBc, and those with a previous voluntary HIV test. CONCLUSIONS: Anti-HCV prevalence rates among injectors in England and Wales, where comprehensive harm reduction programs exist, are lower than rates in other industrialized countries. |
| Domaine : | Drogues illicites / Illicit drugs |
| Refs biblio. : | 32 |
| Affiliation : | Public Health Laboratory Service, Communicable Disease Surveillance Centre, London, UK |
| Centre Emetteur : | 13 OFDT |
| Lien : | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1446497/ |
Accueil
